Akso Health Group
AHG Nasdaq· Services-Business Services, Nec
Last close · Oct 23, 2026
$1.30
KIRA · Stoqly’s AI analyst, in plain words
- Akso Health Group had $13.8M of revenue in fiscal 2026, down 6.4% on the year before. Over five years, revenue changed +51.1% a year on average.
- Its operating margin was −149.7%, up 975.7 pts: of every 100 in sales, about −150 is left after running the business.
- Akso Health Group lost $18.7M in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew −28.3% a year.
- Free cash flow was −$12.8M in fiscal 2026, −92.5% of revenue.
Market cap
$940M
P/E
43.3x
Revenue
$13.8M
Net income
−$18.7M
Free cash flow
−$12.8M
Operating margin
−149.7%
Akso Health Group in 30 seconds · fiscal 2026
Are sales growing?
−6.4%
No. Sales fell 6.4% last year.
Does it make a profit?
−135.0%
No. It lost money last year.
Does profit turn into cash?
−92.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
43.3x
One share costs 43.3 times its yearly profit per share.
What Akso Health Group does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 20-F · Jul 23, 2026
- Legal name
- Akso Health Group
- CIK
- 0001702318
Akso Health Group · AHG
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $6.0M | $13.2M | $2.4M | $14.8M | $13.8M |
| Revenue growth | 241.9% | 119.7% | −81.7% | 512.1% | −6.4% |
| Gross margin | 10.1% | 9.6% | 5.1% | −1.9% | −0.1% |
| Operating margin | −54.3% | −108.2% | −357.8% | −1,125.4% | −149.7% |
| Net income | −$16.9M | −$1.4M | −$9.5M | −$135M | −$18.7M |
| Net margin | −280.9% | −10.3% | −391.8% | −913.4% | −135.0% |
| Diluted EPS | −$0.84 | −$0.06 | $0.21 | $0.48 | $0.03 |
| Cash | |||||
| Cash from operations | −$8.6M | −$3.3M | $1.4M | $1.2M | −$12.8M |
| Capital expenditure | $0.0M | — | — | $0.2M | $0.0M |
| Free cash flow | −$8.6M | — | — | $1.0M | −$12.8M |
| FCF margin | −143.9% | — | — | 6.9% | −92.5% |
| Share count change | 22.1% | 15.1% | 106.3% | 504.4% | 153.5% |
| Debt and strength | |||||
| Cash and short-term investments | $18.4M | $7.9M | $85.2M | $176M | $0.2M |
| Shareholders' equity | $12.3M | $8.7M | $138M | $199M | $181M |
| Current ratio | 1.2x | 1.8x | 39.5x | 14.2x | 21.8x |
| Interest coverage | −4.1x | — | — | — | — |
| Returns and quality | |||||
| Return on equity | −114.0% | −12.9% | −12.9% | −80.0% | −9.8% |
| Return on tangible equity | −137.2% | −15.6% | −6.8% | −74.8% | −10.3% |
| Piotroski F-score | 3 | 3 | 3 | 3 | 5 |
| Altman Z'' | −1.6 | −9.7 | 44.9 | 10.6 | 23.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Akso Health Group · AHG
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.30 a share, the company is worth $940M: 43.3 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001702318). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.